The Latin America, Middle East and Africa Protein A Resin Market would witness market growth of 9.4% CAGR during the forecast period (2022-2028).
Protein A is utilized in R&D and drug discovery for the healthcare businesses mainly for its high selectivity and specificity for human IgG, whose usage is to treat diseases such as cancer and autoimmune diseases. Moreover, it is utilized in the biopharma sector in the procedure of developing GMP-compliant biologics that are authorized for commercialization & clinical usage.
The market is growing due to the rise in the biopharmaceutical & biotechnology businesses in drug advancement procedures, increased expenditure in synthetic biology, and growing monoclonal antibodies research. Furthermore, there has been growth in the demand for protein-engineered goods utilized for therapeutics & vaccine improvement through the biopharmaceutical businesses, which has a positive influence on the international market and is one of the main propelling factors.
Brazil has the most significant healthcare sector in Latin America and spends 9.1% of its GDP on healthcare. In 2021, there were about 88,000 healthcare supplementary services, 532,645 hospital beds, 502,000 physicians, and 89,000 drug stores.. Besides medical treatment and diagnosis, the public facility offers free medicines for some incurable disorders and encourages national vaccination schemes, mainly concentrating on children as well as elderly. Protein A resins are used in treating cancers and other diseases which require the purification of monoclonal antibodies. In addition, many nations are adopting protein A resins to provide better healthcare facilities to their people. This would support the market expansion in LAMEA region.
The Brazil market dominated the LAMEA Protein A Resin Market by Country 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $31.3 million by 2028.The Argentina market is experiencing a CAGR of 10% during (2022 - 2028). Additionally, The UAE market would display a CAGR of 9.1% during (2022 - 2028).
Based on Product Type, the market is segmented into Agarose-based, Glass/Silica-based and Organic Polymer-based. Based on End Use, the market is segmented into Pharmaceutical & Biopharmaceutical Companies, Academic Research Institutes and Others. Based on Type, the market is segmented into Recombinant and Natural. Based on Application, the market is segmented into Antibody Purification and Immunoprecipitation. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
Free Valuable Insights: The Global Protein A Resin Market is Predict to reach $1.9 Billion by 2028, at a CAGR of 6.1%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include General Electric (GE) Co. (GE Healthcare), Repligen Corporation, PerkinElmer, Inc, Thermo Fisher Scientific, Inc., Merck Millipore (Merck Group), Genscript Biotech Corporation, Agilent Technologies, Inc., Abcam plc, and Novasep Holdings SAS (Azulis Capital).
By Product Type
By End Use
By Type
By Application
By Country
Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
Unique Offerings 